Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1984-03-05
1988-03-01
Tarcza, John E.
Chemistry: molecular biology and microbiology
Spore forming or isolating process
530351, 435 68, 4351721, 435948, C12N 500, C12N 1500, A61K 3702, C12R 191
Patent
active
047286148
ABSTRACT:
A stable mutant human T cell line is disclosed which secretes a high titer suppressor inducer factor. This suppressor inducer factor in turn induces production of a T cell suppressor factor which suppressed mitogen-induced T cell proliferation at high dilution. Also disclosed is a general method for mutating lymphoblastoid cell lines to yield mutants secreting enhanced levels of lymphokines.
REFERENCES:
patent: 4239498 (1980-12-01), Rule
patent: 4544632 (1985-10-01), Yamamura et al.
Murakami et al, "Establishment of Human T-Cell Hybridomas Secreting Non-Specific Suppressor Factors", Clinical Research, 31(4), p. 734A (11-1983).
Durand et al, "Mutant Human T Cell Line Constitutively Secreting High Titered Suppressor Factor(s)", Federation Proceedings, 41(3), p. 479 (1982), Abst. #1220.
Uytdehaag et al, "T-T Interactions in the Induction of Antigen Specific Human Suppressor T Lymphocytes in Vitro", Journal of Immunology, 123(2), pp. 646-653 (1979).
Belmont et al, "Physiology of Mixed Leukocyte Reaction Suppressor Factor", Journal of Immunology, 122(3), pp. 1022-1028 (1979).
Rich et al, "Regulatory Mechanisms in Cell Mediated Immune Responses", Journal of Experimental Medicine, 149, pp. 114-126 (1979).
Kapp et al, "Suppression of Antibody and T Cell Proliferative Responses to L-Glutamic Acid, L-Alanine, L-Tyrosine by a T Cell Factor", Journal of Experimental Medicine, 152, pp. 235-240 (1980).
Truitt et al, "Interaction Between T Cells and Non-T Cells in Suppression of Cytotoxic Lymphocyte Responses", Journal of Immunology, 123(2), pp. 745-750 (1979).
David H. Vesole et al., The Journal of Immunology, vol. 123, pp. 1322-1328 (1979).
Warner C. Greene et al., The Journal of Immunology, vol. 129, pp. 1986-1992 (1982).
E. M. Hersh et al., Clin. Exp. Immunol., 17, pp. 463-473 (1974).
John J. Farrar et al., The Journal of Immunology, vol. 125, pp. 2555-2558 (1980).
Steven Gillis et al., J. Exp. Med, The Rockefeller University Press, vol. 152, pp. 1709-1719 (1980).
H. William Schnaper et al., The Journal of Immunology, vol. 132, pp. 2429-2435 (1984).
Ellis H. Reinherz, JAMA, vol. 249, No. 13, pp. 1687-1689 (1983).
Michael Blaese, JAMA, vol. 251, No. 15, pp. 1935-1936 (1984).
A. H. Filipovich et al., The Lancet, pp. 470-475 (1984).
Friedrich Hasler et al., The Journal of Immunology, vol. 131, pp. 768-772 (1983).
"Generation of Functional Human T Cell Hybrids", J. Exp. Med., Irigoyen et al., vol. 154, pp. 1827-1837, Dec. 1981.
"An Inhibitor of DNA Synthesis Produced by Established Lymphoid Cell Lines", Clinical Immunology and Immunopathology, Vesole et al., vol. 14, pp. 489-501, 1979.
"Impaired Release of a T-Cell Specific Suppressor . . . ", Clin. Exp. Immunol., C. Lau et al. (1985), 61, pp. 489-495.
"Graft-Versus-Host Disease in Murine Bone Marrow . . . ", Gorczynski et al., Immuno. Ltrs., 11 (1985), pp. 293-299.
"Purification and Characterization of a Suppressor Activating Factor", Lau et al., 6th Int'l Congress of Immunology, Abstracts, 3.53.6, p. 448, 1986.
"Suppressor Activating Factor (SAF) . . . ", Messino et al., 6th Int'l Congress of Immunology, Abstracts, 6.13.21, 1986.
Dellenbaugh Geoffrey G.
Grochala Richard J.
Levy David J.
Ortho Pharmaceutical
Tarcza John E.
LandOfFree
Mutant human T cell line producing immunosuppressive factor and does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mutant human T cell line producing immunosuppressive factor and , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mutant human T cell line producing immunosuppressive factor and will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-997725